Commitment COM-141
Post-approval commitment for FDA-2024-0041. Category: Labeling Update. Priority: low.
Commitment ID
COM-141
Application
Authority
Food and Drug Administration
Category
Labeling Update
Priority
low
Status
Overdue
Due Date
2024-11-16
Completed At
—
Owner
Lieselotte van der Berg
Created
2022-11-03
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.